BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹469.66m
- IN₹466.60m
- IN₹283.95m
Annual cashflow statement for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.1 | 7.93 | 8.65 | 7.36 | 34.5 |
| Depreciation | |||||
| Non-Cash Items | 0.507 | -0.541 | 2.34 | 0.578 | 0.07 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -17.1 | -12.8 | 8.95 | -31 | -43.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.2 | -1.12 | 23.9 | -19.2 | -6.05 |
| Capital Expenditures | -0.699 | -0.106 | -0.229 | -1 | -2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | 13.4 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.699 | -0.106 | -0.229 | -1 | 11.4 |
| Financing Cash Flow Items | -0.406 | -0.425 | -0.415 | -0.369 | -0.101 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.058 | 0.151 | -1.25 | -0.045 | 25.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.96 | -1.07 | 22.5 | -20.3 | 30.7 |